West Pharmaceutical Services, Inc. (WST)
Company Info
US9553061055
955306105
Jan 13, 1978
Highlights
$22.57B
$6.73
46.31
5.82
$2.88B
$1.00B
$743.90M
$264.65 - $412.94
$361.57
2.59%
1.83
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in West Pharmaceutical Services, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
West Pharmaceutical Services, Inc. had a return of -8.65% year-to-date (YTD) and -8.41% in the last 12 months. Over the past 10 years, West Pharmaceutical Services, Inc. had an annualized return of 20.48%, outperforming the S&P 500 benchmark which had an annualized return of 11.21%.
WST
-8.65%
12.11%
-2.22%
-8.41%
17.33%
20.48%
^GSPC (Benchmark)
25.15%
2.97%
12.53%
31.00%
13.95%
11.21%
Monthly Returns
The table below presents the monthly returns of WST, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 6.00% | -3.93% | 10.42% | -9.61% | -7.29% | -0.61% | -6.99% | 2.44% | -4.29% | 2.59% | -8.65% | ||
| 2023 | 12.93% | 19.36% | 9.29% | 4.32% | -7.37% | 14.30% | -3.72% | 10.56% | -7.79% | -15.17% | 10.27% | 0.39% | 49.97% |
| 2022 | -16.12% | -1.56% | 6.10% | -23.25% | -1.49% | -2.58% | 13.69% | -13.64% | -17.06% | -6.49% | 2.07% | 0.29% | -49.70% |
| 2021 | 5.77% | -6.29% | 0.40% | 16.65% | 5.78% | 3.34% | 14.71% | 9.69% | -6.00% | 1.26% | 3.02% | 5.95% | 65.88% |
| 2020 | 3.84% | -3.46% | 1.12% | 24.43% | 14.15% | 5.15% | 18.43% | 5.61% | -3.19% | -1.03% | 1.19% | 2.96% | 89.05% |
| 2019 | 10.60% | -3.25% | 5.20% | 12.48% | -7.42% | 9.21% | 9.82% | 5.97% | -2.50% | 1.54% | 2.22% | 2.24% | 54.13% |
| 2018 | 1.70% | -12.95% | 1.23% | 0.07% | 5.43% | 6.76% | 10.59% | 6.75% | 5.48% | -14.10% | 3.44% | -10.52% | -0.08% |
| 2017 | -0.08% | -2.55% | -1.04% | 12.95% | 5.42% | -2.58% | -6.03% | -1.87% | 10.59% | 5.49% | -1.45% | -1.26% | 17.02% |
| 2016 | -4.78% | 8.39% | 11.77% | 2.89% | 5.45% | 1.07% | 5.96% | 1.93% | -8.96% | 2.24% | 6.73% | 4.53% | 41.87% |
| 2015 | -7.18% | 10.97% | 10.03% | -11.33% | 1.61% | 7.28% | 3.27% | -6.71% | -3.10% | 11.12% | 5.07% | -4.49% | 14.03% |
| 2014 | -3.09% | -3.94% | -3.36% | -1.29% | -2.97% | 0.21% | -3.15% | 6.58% | 3.06% | 14.78% | 1.48% | 2.36% | 9.53% |
| 2013 | 8.52% | 2.04% | 7.48% | -1.37% | 7.34% | 2.49% | 5.25% | 0.26% | 11.29% | 17.75% | 3.25% | -1.72% | 81.24% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of WST is 30, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
West Pharmaceutical Services, Inc. provided a 0.25% dividend yield over the last twelve months, with an annual payout of $0.81 per share. The company has been increasing its dividends for 27 consecutive years, earning it the status of a dividend aristocrat.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.81 | $0.77 | $0.73 | $0.69 | $0.65 | $0.61 | $0.57 | $0.53 | $0.49 | $0.45 | $0.41 | $0.39 |
Dividend yield | 0.25% | 0.22% | 0.31% | 0.15% | 0.23% | 0.41% | 0.58% | 0.54% | 0.58% | 0.75% | 0.77% | 0.78% |
Monthly Dividends
The table displays the monthly dividend distributions for West Pharmaceutical Services, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.20 | $0.00 | $0.00 | $0.00 | $0.21 | $0.81 | |
| 2023 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.19 | $0.00 | $0.00 | $0.00 | $0.20 | $0.00 | $0.77 |
| 2022 | $0.18 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.18 | $0.00 | $0.00 | $0.00 | $0.19 | $0.00 | $0.73 |
| 2021 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.00 | $0.18 | $0.00 | $0.69 |
| 2020 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.00 | $0.17 | $0.00 | $0.65 |
| 2019 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.16 | $0.00 | $0.00 | $0.61 |
| 2018 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.57 |
| 2017 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.14 | $0.00 | $0.00 | $0.53 |
| 2016 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.13 | $0.00 | $0.00 | $0.49 |
| 2015 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.12 | $0.00 | $0.00 | $0.45 |
| 2014 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.11 | $0.00 | $0.00 | $0.41 |
| 2013 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.10 | $0.00 | $0.00 | $0.39 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the West Pharmaceutical Services, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the West Pharmaceutical Services, Inc. was 55.52%, occurring on Nov 3, 2022. The portfolio has not yet recovered.
The current West Pharmaceutical Services, Inc. drawdown is 31.43%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -55.52% | Dec 31, 2021 | 213 | Nov 3, 2022 | — | — | — |
| -54.76% | Jul 23, 1999 | 816 | Oct 22, 2002 | 288 | Dec 12, 2003 | 1104 |
| -50.52% | Oct 5, 1989 | 285 | Nov 21, 1990 | 371 | May 18, 1992 | 656 |
| -45.12% | Sep 22, 2008 | 116 | Mar 9, 2009 | 824 | Jun 13, 2012 | 940 |
| -43.09% | Jun 8, 1987 | 238 | May 13, 1988 | 309 | Aug 3, 1989 | 547 |
Volatility
Volatility Chart
The current West Pharmaceutical Services, Inc. volatility is 20.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of West Pharmaceutical Services, Inc. compared to its peers in the Medical Instruments & Supplies industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for WST in comparison to other companies of the Medical Instruments & Supplies industry. Currently, WST has a PE value of 46.3. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for WST in comparison to other companies of the Medical Instruments & Supplies industry. Currently, WST has a PEG value of 5.8. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for West Pharmaceutical Services, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |